ExLibris header image
SFX Logo
Title: Glucosylceramide and Glucosylsphingosine Quantitation by Liquid Chromatography-Tandem Mass Spectrometry to Enable In Vivo Preclinical Studies of Neuronopathic Gaucher Disease
Source:

Analytical Chemistry [0003-2700] Rick Hamler, Nastry yr:2017


Collapse list of basic services Basic
Full text
Full text available via American Chemical Society Journals
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Soria, Federico N. "Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration." Human molecular genetics 26.14 (2017): 2603-2615. Link to SFX for this item
2. Hopwood, J. "Glycosphingolipid analysis in a naturally occurring ovine model of acute neuronopathic Gaucher disease." Neurobiology of disease 91 (2016): 143-154. Link to SFX for this item
3. Farfel Becker, T. "Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration." Human molecular genetics 23.4 (2013): 843-54. Link to SFX for this item
4. Hallett, Penelope J. "Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of mouse brain." Neurobiology of aging. 67: 189-200. Link to SFX for this item
5. Sharma, Sandeep K. "Expanding role of molecular chaperones in regulating α-synuclein misfolding; implications in Parkinson’s disease." Cellular and Molecular Life Sciences 74.4 (2017): 617-629. Link to Full Text for this item Link to SFX for this item
6. Malenka, Robert C. "Diversity of transgenic mouse models for selective targeting of midbrain dopamine neurons." Neuron 85.2 (2015): 429-38. Link to SFX for this item
7. Akiyama, H. "Cholesterol glucosylation is catalyzed by transglucosylation reaction of β-glucosidase 1." Biochemical and biophysical research communications 441.4 (2013): 838-43. Link to SFX for this item
8. Cullen, V. "Acid β-glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter α-synuclein processing." Annals of neurology 69.6 (2011): 940-953. Link to Full Text for this item Link to SFX for this item
9. Tropak, M. "Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease." The Journal of biological chemistry 284.35 (2009): 23502-23516. Link to Full Text for this item Link to SFX for this item
10. Ghauharali-van der Vlugt K, Langeveld M, Poppema A, K. "Prominent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher disease." Clinica chimica acta 389.1-2 (2008): 109-113. Link to SFX for this item
11. Orvisky, E. "Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype." Molecular genetics and metabolism 76.4 (2002): 262-70. Link to Full Text for this item Link to SFX for this item
12. Kantak, Pranish A. "Considerations when using cre-driver rodent lines for studying ventral tegmental area circuitry." Neuron 85.2 (2015): 439-45. Link to SFX for this item
13. Langeveld, M. "Type I Gaucher Disease, a Glycosphingolipid Storage Disorder, Is Associated with Insulin Resistance." The Journal of clinical endocrinology and metabolism 93.3 (2008): 845-851. Link to SFX for this item
14. Ginzburg, L. "The pathogenesis of glycosphingolipid storage disorders." Seminars in cell & developmental biology 15.4 (2004): 417-431. Link to SFX for this item
15. Cisneros, Irma E. "Cocaine evokes a profile of oxidative stress and impacts innate antiviral response pathways in astrocytes." Neuropharmacology. 135: 431-443. Link to SFX for this item
16. Kubo, S. "Membrane lipids as therapeutic targets for Parkinson’s disease: a possible link between Lewy pathology and membrane lipids." Expert opinion on therapeutic targets 20.11 (2016): 1301-1310. Link to SFX for this item
17. Rokad, D. "Role of neurotoxicants and traumatic brain injury in α-synuclein protein misfolding and aggregation." Brain research bulletin 133 (2016): 60-70. Link to SFX for this item
18. Bose, S. "Targeting chaperones, heat shock factor-1, and unfolded protein response: Promising therapeutic approaches for neurodegenerative disorders." Ageing research reviews 35 (2016): 155-175. Link to SFX for this item
19. Murugesan, V. "Glucosylsphingosine is a key biomarker of Gaucher disease." American journal of hematology 91.11 (2016): 1082-1089. Link to Full Text for this item Link to SFX for this item
20. Yerbury, J. "Walking the tightrope: proteostasis and neurodegenerative disease." Journal of neurochemistry 137.4 (2016): 489-505. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.